Home » Topics » Regulatory

Regulatory
RSS

Oral treatment for periodontitis filed for approval

Sep. 6, 1996

alpha1-Adrenoceptor antagonist effective in suppressing prostate cancer growth

Sep. 6, 1996

Thalidomide effective in chronic erythema multiforme

Sep. 6, 1996

BTG licenses analgesic combination to Forest

Sep. 6, 1996

FDA approves two pain products from Mallinckrodt

Sep. 6, 1996

Serostim FDA-approved for cachexia in AIDS patients

Aug. 30, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996